Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar joshcollis (< 20) Submitted: 3/8/2011 5:21:46 PM : Outperform Start Price: $6.01 ARIA Score: +177.66

Solid management team and interesting products

Report this Post Reply

Featured Broker Partners


Advertisement